Galectin Therapeutics
GALT
#8232
Rank
HK$2.72 B
Marketcap
HK$27.07
Share price
7.14%
Change (1 day)
-11.13%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): -HK$3.75

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$3.77. In 2025 the company made an earnings per share (EPS) of -HK$3.77 an increase over its 2024 EPS that were of -HK$5.96.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$3.75-0.48%
2025-HK$3.77-36.84%
2024-HK$5.962.7%
2023-HK$5.8113.85%
2022-HK$5.1025%
2021-HK$4.0826.83%
2020-HK$3.225.13%
2019-HK$3.062.63%
2018-HK$2.98-22.45%
2017-HK$3.84-35.53%
2016-HK$5.96-13.64%
2015-HK$6.9012.82%
2014-HK$6.12-40%
2013-HK$10.2080.56%
2012-HK$5.65-32.08%
2011-HK$8.3213.98%
2010-HK$7.30-22.5%
2009-HK$9.41185.71%
2008-HK$3.29-70.83%
2007-HK$11.30118.18%
2006-HK$5.18-54.17%
2005-HK$11.30-14.29%
2004-HK$13.1847.37%
2003-HK$8.94-13.64%
2002-HK$10.36-24.14%
2001-HK$13.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
-HK$95.87 2,445.83%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-HK$0.55-85.42%๐Ÿ‡บ๐Ÿ‡ธ USA